Technical Assistance to Provide High-Quality Voluntary Medical Male Circumcision (VMMC) Services to Programs Supported by the President’s Emergency Plan for AIDS Relief (PEPFAR) | CDC RFA GH15 153702CONT16

Opportunity Information: Apply for CDC RFA GH15 153702CONT16

The Centers for Disease Control and Prevention (CDC) released a continuation funding opportunity titled "Technical Assistance to Provide High-Quality Voluntary Medical Male Circumcision (VMMC) Services to Programs Supported by the President's Emergency Plan for AIDS Relief (PEPFAR)." The purpose of this award is to support ongoing technical assistance activities that help PEPFAR-supported programs deliver high-quality VMMC services, a proven HIV prevention intervention in settings where heterosexual transmission is a major driver of the epidemic and where VMMC is part of the national and PEPFAR HIV prevention strategy. Because this is framed as technical assistance, the emphasis is less on directly running service delivery sites and more on strengthening the systems, standards, training, monitoring, and implementation support that enable safe, effective, and scalable circumcision services.

This opportunity is explicitly a continuation award and is not open to new applicants. The description states that the funding is "intended only for grantees previously awarded under GH15-1537," meaning only organizations that already received awards under the earlier CDC funding announcement (GH15-1537) are eligible to receive additional support under this continuation action. In practice, continuation announcements like this are used to extend or sustain work that is already underway, maintain staffing and operational capacity, and allow projects to meet multi-year objectives without interruption, rather than to launch brand-new programs or onboard additional implementing partners.

Administratively, the award is offered as a cooperative agreement, which typically means CDC expects to have substantial involvement in the funded work. That involvement can include collaboration on technical direction, alignment with CDC and PEPFAR priorities, review of work plans, participation in technical consultations, and ensuring that funded activities follow evolving clinical guidance and program quality standards. The activity category is listed as Health, and the associated CFDA number is 93.067, which corresponds to CDC HIV-related assistance programs commonly linked with PEPFAR-supported efforts. The opportunity is associated with the funding opportunity number "CDC RFA GH15 153702CONT16," indicating it is a continuation (CONT) action tied to the earlier RFA.

The source data indicates an expected number of five awards, suggesting a small set of existing recipients would continue receiving funding. The award ceiling is listed as 0, which often appears in continuation notices when amounts are determined by prior-year budgets, availability of appropriations, satisfactory performance, and approved continuation applications rather than a newly competed maximum. The original closing date is shown as November 24, 2015, and the posting (creation) date is September 22, 2015, reflecting the timeframe in which existing grantees would have submitted continuation materials or been reviewed for continued support.

In terms of what the funded work generally supports, "high-quality" VMMC technical assistance usually covers maintaining clinical safety and quality assurance (including infection prevention and control, adverse event monitoring and management, and compliance with surgical standards), strengthening provider training and certification, improving service delivery efficiency and client flow, supporting demand creation strategies that are ethical and evidence-based, and reinforcing data systems for monitoring coverage, quality, and outcomes. It can also include guidance on supply chain readiness for VMMC commodities, mentoring and supportive supervision models, integration with HIV testing services and linkage to prevention and treatment services, and ensuring services are voluntary and consistent with human rights and informed consent principles.

Overall, this grant opportunity is best understood as a targeted, non-competitive continuation mechanism by CDC to sustain specialized technical assistance that helps PEPFAR-supported countries and implementing partners maintain and improve VMMC program quality, safety, and performance. It is designed to keep existing, previously selected grantees working with CDC and PEPFAR stakeholders to support consistent delivery of VMMC as part of comprehensive HIV prevention programming.

• The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Technical Assistance to Provide High-Quality Voluntary Medical Male Circumcision (VMMC) Services to Programs Supported by the President’s Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
• This funding opportunity was created on 2015-09-22.
• Applicants must submit their applications by 2015-11-24. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 5 candidate(s).
• Eligible applicants include: Others.

Apply for CDC RFA GH15 153702CONT16

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: